Gene expression levels of CSNK1A1 and AAC-11, but not NME1, in tumor tissues as prognostic factors in NSCLC patients

Case Reports and Clinical Practice Review

Volumn 16, Issue 8, 2010, Pages

  Wang, Zhuomin ^a,b   Liu, Hongyu ^a   Liu, Baoxing ^a   Ma, Wei ^a   Xue, Xingyang ^a   Chen, Jun ^a   Zhou, Qinghua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b The 452nd Hospital of the People's Liberation Army of China   (China)

Author keywords

AAC 11; CSNK2A1; NME1; NSCLC; Prognosis; RT PCR

Indexed keywords

ANTIAPOPTOSIS CLONE 11 PROTEIN; CASEIN KINASE 2 ALPHA SUBUNIT; CASEIN KINASE II; GENE PRODUCT; MESSENGER RNA; PROTEIN NME1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; API5 PROTEIN, HUMAN; APOPTOSIS REGULATORY PROTEIN; NME1 PROTEIN, HUMAN; NUCLEAR PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE NM23; ANTIAPOPTOSIS CLONE 11; APOPTOSIS INHIBITOR; CASEIN KINASE II ALPHA; NUCLEOSIDE DIPHOSPHATE KINASE A; RNA;

ADULT; ARTICLE; CANCER SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RETROSPECTIVE STUDY; RNA EXTRACTION; TISSUE SECTION; AGED; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, NON-SMALL-CELL LUNG; CASEIN KINASE II; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; NUCLEAR PROTEINS; PROGNOSIS; RNA, MESSENGER;

EID: 77956194139     PISSN: 15076164     EISSN: 16433742     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Niklinski J et al: Prognostic molecular markers in non-small cell lung cancer. Lung Cancer, 2001; 34(Suppl.2): S53-58
2. Moldvay J et al: Predictive survival markers in patients with surgically resected non-small cell lung carcinoma. Clin Cancer Res, 2000; 6(3): 1125-34
3. Ludwig JA, Weinstein JN: Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer, 2005; 5(11): 845-56
4. Lossos IS et al: Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med, 2004; 350(18): 1828-37
5. Pluciennik E et al: Breast cancer relapse prediction based on multi-gene RT-PCR algorithm. Med Sci Monit, 2010; 16(3): CR132-36
6. Lehmann U, Kreipe H: Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies. Methods, 2001; 25(4): 409-18
7. Paik S et al: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med, 2004; 351(27): 2817-26
8. Ahmad KA et al: Targeting CK2 for cancer therapy. Anticancer Drugs, 2005; 16(10): 1037-43
9. Wirkner U et al: The human gene (CSNK2A1) coding for the casein kinase II subunit alpha is located on chromosome 20 and contains tandemly arranged Alu repeats. Genomics, 1994; 19(2): 257-65
10. Pinna LA: Protein kinase CK2: a challenge to canons. J Cell Sci, 2002; 115(Pt 20): 3873-78
11. Olsten ME, Litchfield DW: Order or chaos? An evaluation of the regulation of protein kinase CK2. Biochem Cell Biol, 2004; 82(6): 681-93
12. Tewari M et al: AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal. Cancer Res, 1997; 57(18): 4063-69
13. Steeg PS et al: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst, 1988; 80(3): 200-4
14. Hsu NY et al: Prognostic significance of expression of nm23-H1 and focal adhesion kinase in non-small cell lung cancer. Oncol Rep, 2007; 18(1): 81-85
15. Liu L et al: Slot blot analysis of metastasis suppression gene nm23 expression in human lung cancer. Hua Xi Yi Ke Da Xue Xue Bao, 1998; 29 (4): 364-67
16. Volm M, Mattern J, Koomagi R: Association between nm23-H1 expression, proliferation and apoptosis in non-small cell lung carcinomas. Clin Exp Metastasis, 1998; 16(7): 595-602
17. Lai WW et al: Immunohistochemical analysis of nm23-H1 in stage I nonsmall cell lung cancer: a useful marker in prediction of metastases. Ann Thorac Surg, 1996; 62(5): 1500-4
18. Chen J, Byrne GE Jr., Lossos IS: Optimization of RNA extraction from formalin-fixed, paraffin-embedded lymphoid tissues. Diagn Mol Pathol, 2007; 16(2): 61-72
19. Zhang F et al: Application of RT-PCR in formalin-fixed and paraffin-embedded lung cancer tissues. Acta Pharmacol Sin, 2010; 31(1): 111-17
20. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 2001; 25(4): 402-8
21. Cronin M et al: Measurement of gene expression in archival paraffinembedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. Am J Pathol, 2004; 164(1): 35-42
22. Chen HY et al: A five-gene signature and clinical outcome in non-smallcell lung cancer. N Engl J Med, 2007; 356(1): 11-20
23. Bast RC Jr., Hortobagyi GN: Individualized care for patients with cancer a work in progress. N Engl J Med, 2004; 351(27): 2865-67
24. Tawfic S et al: Protein kinase CK2 signal in neoplasia. Histol Histopathol, 2001; 16(2): 573-82
25. Unger GM et al: Protein kinase CK2 as regulator of cell survival: implications for cancer therapy. Curr Cancer Drug Targets, 2004; 4(1): 77-84
26. Landesman-Bollag E et al: Protein kinase CK2 in mammary gland tumorigenesis. Oncogene, 2001, 20(25): 3247-57
27. Daya-Makin M et al: Activation of a tumor-associated protein kinase (p40TAK) and casein kinase 2 in human squamous cell carcinomas and adenocarcinomas of the lung. Cancer Res, 1994; 54(8): 2262-68
28. Faust RA et al: Antisense oligonucleotides against protein kinase CK2alpha inhibit growth of squamous cell carcinoma of the head and neck in vitro. Head Neck, 2000; 22(4): 341-46
29. Yenice S et al: Nuclear casein kinase 2 (CK-2) activity in human normal, benign hyperplastic, and cancerous prostate. Prostate, 1994; 24(1): 1116
30. Stalter G et al: Asymmetric expression of protein kinase CK2 subunits in human kidney tumors. Biochem Biophys Res Commun, 1994; 202(1): 141-47
31. Guo C et al: A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells. J Biol Chem, 2001; 276(8): 5992-99
32. Knosel T et al: Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer. Neoplasia, 2005; 7(8): 741-47
33. Oc P et al: Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung. Clin Cancer Res, 2004; 10(17): 5792-803
34. Sasaki H et al: Expression of the antiapoptosis gene, AAC-11, as a prognosis marker in non-small cell lung cancer. Lung Cancer, 2001; 34(1): 53-57
35. Sgouros J et al: Correlation of nm23-H1 gene expression with clinical outcome in patients with advanced breast cancer. In Vivo, 2007; 21(3): 519-22
36. Mao H et al: Loss of nm23 expression predicts distal metastases and poorer survival for breast cancer. Int J Oncol, 2001; 18(3): 587-91
37. Katakura H et al: Clinical significance of nm23 expression in resected pathologic-stage I, non-small cell lung cancer. Ann Thorac Surg, 2002; 73(4): 1060-64
38. Brundage MD, Davies D, Mackillop WJ: Prognostic factors in non-small cell lung cancer: a decade of progress. Chest, 2002; 122(3): 1037-57
39. Junker K: Prognostic factors in stage I/II non-small cell lung cancer. Lung Cancer, 2001; 33(Suppl.1): S17-24